Rainmed Medical Ltd., a company listed on the main board of the Hong Kong Stock Exchange, has announced a subscription of new shares under a general mandate. The company has entered into a subscription agreement with Apsara Technology Limited, an independent third party, for the issuance of 233,559,800 new ordinary shares at a subscription price of HK$0.163 per share. This transaction is subject to the fulfillment of certain conditions outlined in the agreement. Shareholders and potential subscribers are advised to exercise caution when dealing with the company's shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rainmed Medical Ltd. published the original content used to generate this news brief on May 26, 2025, and is solely responsible for the information contained therein.